Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1981 Sep;57(671):602–603. doi: 10.1136/pgmj.57.671.602

Hydrallazine alone in acute left ventricular failure

A J L Clark, H B McMichael
PMCID: PMC2426154  PMID: 7329902

Abstract

A patient presented with severe acute left ventricular failure and was treated with hydrallazine and oxygen alone. He made a rapid and full recovery as judged by clinical, radiological and blood gas evidence.

Full text

PDF
602

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chatterjee K., Parmley W. W., Massie B., Greenberg B., Werner J., Klausner S., Norman A. Oral hydralazine therapy for chronic refractory heart failure. Circulation. 1976 Dec;54(6):879–883. doi: 10.1161/01.cir.54.6.879. [DOI] [PubMed] [Google Scholar]
  2. Chatterjee K., Parmley W. W. Vasodilator treatment for acute and chronic heart failure. Br Heart J. 1977 Jul;39(7):706–720. doi: 10.1136/hrt.39.7.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fitchett D. H., Neto J. A., Oakley C. M., Goodwin J. F. Hydralazine in the management of left ventricular failure. Am J Cardiol. 1979 Aug;44(2):303–309. doi: 10.1016/0002-9149(79)90321-7. [DOI] [PubMed] [Google Scholar]
  4. Mason D. T. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure. Am J Med. 1978 Jul;65(1):106–125. doi: 10.1016/0002-9343(78)90700-3. [DOI] [PubMed] [Google Scholar]
  5. Opie L. H. Drugs and the heart. VI. Vasodilating drugs. Lancet. 1980 May 3;1(8175):966–972. doi: 10.1016/s0140-6736(80)91413-0. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES